Researchers now know that MS starts way earlier than the clinical onset, creating the real possibility that MS could one day be controlled.

The award ceremonies at ASHG are some of the best sessions of the conference. All of the speeches are moving, and each awardee is deserving. But this year, one stood out. And that is when Eric Green, ...

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

BioAgilytix now operates 355,000-square-feet of laboratory facilities, including 24,000-square-feet dedicated to LC/MS.

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.

In this GEN interview, Nobel Laureate David Baker, PhD, emphasizes that designing proteins from scratch is reality and unpacks what's needed for AI to transform medicine.

As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in the coming days, analysts and especially investors will keep their eyes on whether the ...

The peptide lab is designed to produce a range of molecules, including linear peptides, cyclic peptides, and peptide-drug conjugates.

Researchers say findings help to bridge the structure of the genome to its function in managing how genes are turned on and off.

A new mechanism explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer.

Different variants of a gene, known as isoforms, can be transcribed and translated at varying levels within a cell or tissue. These isoforms are commonly a result of alternative splicing, which ...

In this GEN webinar, a distinguished panel of experts discuss next-generation expression systems, optimized screening methods, and integrated development strategies that are enabling higher-performing ...